| Cover | May 20, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | May 20, 2024 |
| Entity File Number | 001-15697 |
| Entity Registrant Name | ELITE PHARMACEUTICALS, INC. |
| Entity Central Index Key | 0001053369 |
| Entity Tax Identification Number | 22-3542636 |
| Entity Incorporation, State or Country Code | NV |
| Entity Address, Address Line One | 165 Ludlow Avenue |
| Entity Address, City or Town | Northvale |
| Entity Address, State or Province | NJ |
| Entity Address, Postal Zip Code | 07647 |
| City Area Code | (201) |
| Local Phone Number | 750-2646 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | ELTP |
| Entity Emerging Growth Company | false |
